This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,353.28 firm fixed-price delivery order is for the supply of 4,566,438,493 units of the drug Rivastigmine 1.5 mg capsules. The contract has a completion date of November 15, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.
Generated 2/13/25, 9:37 AM